发明名称 |
THERAPEUTIC AGENT FOR INFLAMMATORY BOWEL DISEASE |
摘要 |
<p>Disclosed is a therapeutic agent for inflammatory bowel disease comprising 5-chloro-6-(2-iminopyrrolidin-1-yl)methyl- 2,4(1H,3H)-pyrimidinedione or a pharmaceutically acceptable salt thereof as an active ingredient. An effective and safe therapeutic agent for inflammatory bowel disease including ulcerative colitis and Crohn's disease can be provided. The balance between the therapeutic effect on a chronic inflammation such as inflammatory bowel disease and the adverse side effect of the compound is superior to those of an aminosalicylic acid preparation and a corticosteroid preparation. The compound shows an unexpected effect beyond a mere antidiarrheal effect.</p> |
申请公布号 |
WO2007122812(A1) |
申请公布日期 |
2007.11.01 |
申请号 |
WO2007JP00403 |
申请日期 |
2007.04.12 |
申请人 |
TAIHO PHARMACEUTICAL CO., LTD.;TAKEBAYASHI, YUJI |
发明人 |
TAKEBAYASHI, YUJI |
分类号 |
A61K31/506;A61P1/04;C07D403/06 |
主分类号 |
A61K31/506 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|